Unlocking Insights: The Impact of New Medical Device EU Regulation (MDR)
Learn about the impact of the new EU Medical Device Regulation (MDR) on the development of medical devices and drug-device combination products. Gain...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
Emergency Use Authorizations (EUA) are a mechanism that allows the U.S. FDA to facilitate the availability of medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats, including emerging infectious diseases such as COVID-19 and pandemic influenza, during public health emergencies. Products that receive emergency health authorizations may be legally marketed and sold in the U.S. for the duration of the emergency or until authorization is revoked by FDA.
Listen to the full episode on Veristat’s Advancing Revolutionary Therapies (ART) Podcast to learn more about the four primary criteria for an Emergency Use Authorization, navigating the U.S. regulatory environment, and the many nuances key to the success of an Emergency Use Authorization application.
Learning Points
Learn about the impact of the new EU Medical Device Regulation (MDR) on the development of medical devices and drug-device combination products. Gain...
As the industry continues to adopt a patient-centric approach, the use of real-world data is becoming increasingly essential in informing drug...
Stay informed about the future trends in European regulations on medicines with Veristat and TOPRA. Explore the new Pharmaceutical Strategy for...